IP Library Assignment 012341/0861
Patent Assignment
Reel/Frame 012341/0861

Assignment of Assignor's Interest

Recorded: 2001-12-10 Pages: 3
Assignors
STEGMANN, THOMAS J.
Executed: 2001-11-29
KORDYUM, VITALIY A.
Executed: 2001-11-26
SLAVCHENKO, IRYNA YU
Executed: 2001-11-26
CHERNYKH, SVITLANA I.
Executed: 2001-11-26
VOZIANOV, OLEKSANDR F.
Executed: 2001-11-26
Assignee
PHAGE BIOTECHNOLOGY CORPORATION
14272 FRANKLIN AVENUE, SUITE 100, TUSTIN, CALIFORNIA, 92780
Covered Property (1)
Method of Producing Biologically Active Human Acidic Fibroblast Growth Factor and Its Use in Promoting Angiogenesis
Patent: 6,642,026 →
Application: 09/929,945 →
Publication: US 2002/0155532
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 15, 2005
From: PHAGE BIOTECHNOLOGY CORPORATION
To: CARDIOVASCULAR BIOTHERAPEUTICS, INC.
Reel/Frame 016263/0507 →
Security Agreement Mar 23, 2006
From: CARDIOVASCULAR BIOTHERAPEUTICS, INC.
To: PROMETHEAN ASSET MANAGEMENT L.L.C.
Reel/Frame 017344/0912 →
Security Agreement Nov 24, 2008
From: PHAGE BIOTECHNOLOGY CORPORATION
To: RICHARD RITTER, COLLATERAL AGENT
Reel/Frame 021936/0646 →
Security Interest Apr 22, 2009
From: CARDIOVASCULAR BIOTHERAPEUTICS, INC.
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 022575/0794 →
Amendment to Security Agreement Aug 25, 2009
From: PHAGE BIOTECHNOLOGY CORPORATION
To: RITTER, RICHARD, COLLATERAL AGENT
Reel/Frame 023134/0152 →
Assignment of Assignor's Interest Oct 16, 2009
From: CARDIOVASCULAR BIOTHERAPEUTICS, INC.
To: PHAGE BIOTECHNOLOGY CORPORATION
Reel/Frame 023379/0723 →
Assignment of Assignor's Interest May 7, 2010
From: PHAGE BIOTECHNOLOGY CORPORATION
To: NEW TECHNOLOGIES HOLDING PTE. LTD.
Reel/Frame 024351/0625 →
Security Interest Termination Mar 11, 2015
From: KNOBBE, MARTENS, OLSON & BEAR, LLP
To: CARDIOVASCULAR BIOTHERAPEUTICS, INC.
Reel/Frame 035277/0648 →